According to the recent study the interventional cardiology and peripheral vascular device market is projected to reach an estimated $38.3 billion by 2030 from $25.9 billion in 2023, at a CAGR of 5.6% from 2024 to 2030. Growth in this market is primarily driven by growing elderly population, rise in prevalence of chronic diseases, and advancements in medical technology and research.

A more than 150 – page report is developed to understand trends, opportunities and forecast in interventional cardiology and peripheral vascular device market by type (interventional cardiology and peripheral vascular device), device (angioplasty balloons, angioplasty stents, angioplasty catheters, EVAR stent graft, IVC filter, embolic protection device, guidewires, arteriotomy closure device, intravascular ultrasound system, and synthetic surgical graft), end user (hospitals and ambulatory surgical centers), and region (North America, Europe, Asia Pacific, and the Rest of the World).

“Interventional cardiology market is expected to remain the largest segment during the forecast period.”

Based on type, the interventional cardiology and peripheral vascular device market is segmented into interventional cardiology and peripheral vascular device. Lucintel forecasts that the interventional cardiology market is expected to remain the largest segment because of new technology innovations and aging population.

“Within the interventional cardiology and peripheral vascular device market, the hospitals segment is expected to remain the largest end use”

Based on end use the hospitals segment is expected to witness the highest growth over the forecast period due to the growing public-private partnerships to improve access to healthcare services along with rapid developments in healthcare infrastructure and improving access to healthcare services. These are the major driving factors for growth in this segment over the forecast period.

“Asia pacific will dominate the interventional cardiology and peripheral vascular device market in near future”

Asia Pacific is expected to be the largest region with the highest growth over the forecast period due to the presence of a large pool of respiratory patients, increasing healthcare expenditure, rapidly developing healthcare infrastructure, rising per capita income, growing middle-class population, and growing prevalence of tobacco smoking in this region.

Major players of interventional cardiology and peripheral vascular device market are adopting various growth strategies like new product launches, expansions, merger and acquisitions, partnerships, agreements, and collaborations to expand their presence in this market. Abbott Laboratories, Boston Scientific Corporation, Edwards Lifesciences Corporation, Medtronics Public Limited Company, C. R. Bard, Inc., Cook Medical Inc., Terumo Corporation, Cardinal Health Inc are among the major interventional cardiology and peripheral vascular device providers.

This unique research report will enable you to make confident business decisions in this globally competitive marketplace. For a detailed table of contents, contact Lucintel at +1-972-636-5056 or write us at [email protected]